Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000726825 | SCV000703330 | uncertain significance | not provided | 2016-11-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000594188 | SCV000722495 | likely benign | not specified | 2017-08-28 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001083037 | SCV001009640 | likely benign | Duchenne muscular dystrophy | 2025-01-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002395523 | SCV002674412 | likely benign | Cardiovascular phenotype | 2022-08-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001834874 | SCV002087745 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2020-05-12 | no assertion criteria provided | clinical testing |